Seaport Therapeutics Inc. Common Stock

SPTX | NASDAQ

$20.05

+$0.45 (+2.30%)

Nov 2, 2026, 12:11 PM ET · Market open

TTM Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026
Net Income	-88.01M	-25.41M
Depreciation & Amortization	708K	357K
Stock-Based Compensation	2.57M	2.57M
Other Working Capital	-1.55M	-247K
Other Non-Cash Items	36.28M	-223K
Deferred Income Tax	n/a	n/a
Change in Working Capital	2.14M	2.53M
Operating Cash Flow	-46.31M	-20.17M
Capital Expenditures	n/a	n/a
Cash Acquisitions	n/a	n/a
Purchase of Investments	-300.65M	-47.15M
Sales Maturities Of Investments	125M	75M
Other Investing Acitivies	n/a	n/a
Investing Cash Flow	-175.65M	27.85M
Debt Repayment	n/a	n/a
Common Stock Repurchased	n/a	n/a
Dividend Paid	n/a	n/a
Other Financial Acitivies	239.34M	-783K
Financial Cash Flow	240.15M	-783K
Net Cash Flow	18.18M	6.87M
Free Cash Flow	-46.31M	-20.17M
Adj. Free Cash Flow	-48.88M	-22.74M
Maintenance CapEx	n/a	n/a
Growth CapEx	n/a	n/a
Owner Earnings	n/a	n/a